RAS/C-RAF interaction: A new pharmacological target in Kras-driven lung cancer.

Project Information

IVORIaN

Grant agreement ID: 748273

DOI 10.3030/748273

Closed project

EC signature date 17 March 2017

Start date 1 June 2017

End date 31 May 2019

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 183 454,80

EU contribution € 183 454,80

Coordinated by

THE FRANCIS CRICK INSTITUTE LIMITED
United Kingdom